The following inclusion criteria were applied: (1) infection with SARS-CoV-2 virus prior to neurological symptoms, (2) presence of anti-MOG antibodies in serum and/or in the CSF, (3) presence of encephalopathy/encephalitis, with particular emphasis on changes in MRI, without inflammatory changes in other CNS structures (e.g., myelitis, ON, and ADEM), and (4) no other plausible explanation for the above. Here, MOG is linked to Encephalopathy.